Effectiveness of Acapella and ELTGOL Technique to Promote Airway Clearance in COPD:a Comparative Study

September 23, 2014 updated by: STEFFI VARGHESE P, PSG College of Physiotherapy

Effectiveness of Acapella and ELTGOL (Expiration in Lateral Position With Open Glottis)Technique to Promote Airway Clearance in COPD Patients:a Comparative Study

To compare the efficacy of acapella and expiration against open glottis (ELTGOL) technique in promoting airway clearance of chronic obstructive pulmonary disease (COPD) patients

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Detailed Description

This study is carried out to determine the effectiveness of acapella and expiration in lateral position with open glottis to clear the secretion in COPD patients. The sessions will be carried twice daily for twenty minutes. The outcome measures are values of pre and post intervention fev1/fvc and breathlessness cough sputum scale. Duration of the study will be for five days.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • India
    • Tamilnadu
      • Coimbatore, Tamilnadu, India, 641004
        • Recruiting
        • Steffi Varghese
        • Contact:
          • mahesh, mpt
          • Phone Number: 04222570170
        • Contact:
          • shanmugapriya, mpt
          • Phone Number: 04222570170

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

28 years to 78 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Mild copd
  • Moderate copd
  • Patient able to sustain expiratory flow greater than 15l/min
  • Patient expectorate more than 25.-30ml

Exclusion Criteria:

  • Severe copd
  • Peripheral oxygen saturation lower than 85%
  • Rr>35breaths/min
  • Current acute chest pain
  • Recent history of haemoptysis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acapella
Acapella is given to the patients twice daily for 20 min.
Device: Acapella
Treatment time for 20 min twice daily
Other Names:
  • ACAPELLA DHD
Experimental: ELTGOL
Expiration with open glottis in lateral position is done twice daily for 20 min
Other: ELTGOL
ELTGOL technique 20 min twice daily
Other Names:
  • Expiration in lateral position with open glottis for twenty min twice daily.
Active Comparator: conventional physiotherapy
Conventional physiotherapy like breathing exercise, active coughing, chest mobilisation was encouraged twice daily for 20 min.
Other: conventional physiotherapy
Conventional physiotherapy was given twice daily for 20 min

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Force expiratory volume in one second
Time Frame: change from baseline at 30 minutes
Fev1/fvc values were noted after pre and post intervention of airway clearance manoeuver
change from baseline at 30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in breathlessness cough sputum score
Time Frame: change from baseline at 5 days
Bcss scale was interviewed to the patient on first day and the fifth day. The changes were noted.
change from baseline at 5 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

PSG College of Physiotherapy

Investigators

  • Principal Investigator: steffi varghese, mpt, psg ims&r

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2014

Primary Completion (Anticipated)

December 1, 2014

Study Completion (Anticipated)

January 1, 2015

Study Registration Dates

First Submitted

September 4, 2014

First Submitted That Met QC Criteria

September 23, 2014

First Posted (Estimate)

September 25, 2014

Study Record Updates

Last Update Posted (Estimate)

September 25, 2014

Last Update Submitted That Met QC Criteria

September 23, 2014

Last Verified

September 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 14\305

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Clinical Trials on Acapella

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe